Cue Biopharma, Inc. (CUE)
4.60
+0.10
(+2.22%)
USD |
NASDAQ |
Nov 20, 12:17
Cue Biopharma Cash from Investing (Quarterly) : 0.00 for Sept. 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.00 |
| June 30, 2026 | 0.00 |
| March 31, 2026 | -0.121M |
| December 31, 2025 | 7.02M |
| September 30, 2025 | -6.768M |
| June 30, 2025 | -0.027M |
| March 31, 2025 | -0.15M |
| December 31, 2024 | -0.001M |
| September 30, 2024 | 0.098M |
| June 30, 2024 | -0.01M |
| March 31, 2024 | -0.055M |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 5.00M |
| June 30, 2023 | 5.00M |
| March 31, 2023 | 15.00M |
| December 31, 2022 | 4.999M |
| September 30, 2022 | -29.52M |
| June 30, 2022 | -0.062M |
| Date | Value |
|---|---|
| March 31, 2022 | -0.027M |
| December 31, 2021 | 0.0005M |
| September 30, 2021 | -0.011M |
| June 30, 2021 | -0.233M |
| March 31, 2021 | 9.352M |
| December 31, 2020 | 9.892M |
| September 30, 2020 | 4.654M |
| June 30, 2020 | -0.14M |
| March 31, 2020 | -9.95M |
| December 31, 2019 | -15.15M |
| September 30, 2019 | 3.984M |
| June 30, 2019 | 5.127M |
| March 31, 2019 | 9.481M |
| December 31, 2018 | 4.687M |
| September 30, 2018 | -23.61M |
| June 30, 2018 | -0.76M |
| March 31, 2018 | -0.673M |
| December 31, 2017 | -0.0189M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Cypherpunk Technologies, Inc. | -6.00M |
| Yarrow Bioscience, Inc. | -5.00M |
| Faeth Therapeutics, Inc. | 0.175M |
| Indaptus Therapeutics, Inc. | 0.0882M |
| Pyxis Oncology, Inc. | -37.29M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -10.08M |
| Cash from Financing (Quarterly) | 50.63M |
| Free Cash Flow | -51.22M |
| Free Cash Flow Per Share (Quarterly) | -0.9546 |
| Free Cash Flow to Equity (Quarterly) | -10.40M |
| Free Cash Flow to Firm (Quarterly) | -10.08M |
| Free Cash Flow Yield | -143.6% |